Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Carshalton urostomy set triangular 25mm
23985859803
|
Carshalton urostomy set triangular 25mm | Urostomy Sets | Stoma Appliances | No data available |
|
Carshalton urostomy set triangular 32mm
23985859804
|
Carshalton urostomy set triangular 32mm | Urostomy Sets | Stoma Appliances | No data available |
|
Carshalton urostomy set triangular 38mm
23985859805
|
Carshalton urostomy set triangular 38mm | Urostomy Sets | Stoma Appliances | No data available |
|
Carteolol 1% eye drops
1106000K0AAAAAA
|
Carteolol hydrochloride (Eye) | Carteolol hydrochloride | Eye | No data available |
|
Carteolol 2% eye drops
1106000K0AAABAB
|
Carteolol hydrochloride (Eye) | Carteolol hydrochloride | Eye | No data available |
|
Carvedilol 1.5mg/5ml oral suspension
020400080AAAMAM
|
Carvedilol | Carvedilol | Cardiovascular System | No data available |
|
Carvedilol 3.125mg/5ml oral suspension
020400080AAADAD
|
Carvedilol | Carvedilol | Cardiovascular System | No data available |
|
Carvedilol 3.5mg suppositories
020400080AAANAN
|
Carvedilol | Carvedilol | Cardiovascular System | No data available |
|
Carylderm 0.5% alcoholic lotion
1310040F0BBAAAA
|
Carylderm | Carbaryl | Skin | No data available |
|
Carylderm 1% aqueous liquid
1310040F0BBADAF
|
Carylderm | Carbaryl | Skin | No data available |
|
Cascara dry extract 130mg / Senna leaf 32mg tablets
010602000AAACAC
|
Generic compound preparation BNF 0106020 | Other stimulant laxative preparations | Gastro-Intestinal System | No data available |
|
Cascor 2mg tablets
0205040D0BCAAAB
|
Cascor (Hypertension) | Doxazosin mesilate | Cardiovascular System | No data available |
|
Cascor 4mg tablets
0205040D0BCABAC
|
Cascor (Hypertension) | Doxazosin mesilate | Cardiovascular System | No data available |
|
Casilan 90 powder
0913391A0BBAAAA
|
Casilan 90 pdr disc or non ACBS energy and protein fortifier | Pdr disc or non ACBS energy and protein fortifier (0913391) | Nutrition and Blood | No data available |
|
Caspofungin 70mg powder for solution for infusion vials
0502040C0AAABAB
|
Caspofungin | Caspofungin | Infections | No data available |
|
Catapres 300microgram tablets
0205020E0BBABAD
|
Catapres | Clonidine hydrochloride | Cardiovascular System | No data available |
|
Catapres PL Perlongets 250microgram capsules
0205020E0BBACAA
|
Catapres | Clonidine hydrochloride | Cardiovascular System | No data available |
|
Catapres TTS 3 patches
0205020E0BBAGAH
|
Catapres | Clonidine hydrochloride | Cardiovascular System | No data available |
|
Cath-Fix catheter securement device large
21012200138
|
Cath-Fix catheter securement device large | Other Appliances | Appliances | No data available |
|
Cath-Fix catheter securement device medium
21012200137
|
Cath-Fix catheter securement device medium | Other Appliances | Appliances | No data available |
|
Cath-Fix catheter securement device small
21012200136
|
Cath-Fix catheter securement device small | Other Appliances | Appliances | No data available |
|
Cath-It Advance catheter male 12Ch-16Ch
21020001460
|
Cath-It Advance catheter male 12Ch-16Ch | Catheters | Appliances | No data available |
|
Catiolanze 50micrograms/ml eye dps emulsn 0.3ml unit dose
1106000L0BFAAAD
|
Catiolanze | Latanoprost | Eye | No data available |
|
Catridecacog 2,500unit inj vials
0211000ABAAAAAA
|
Factor XIII (Recombinant) | Factor XIII (Recombinant) | Cardiovascular System | No data available |
|
Catrix dressing sachets
20031700115
|
Catrix dressing sachets | Wound Management & Other Dressings | Dressings | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.